{
	"title": "Anti-hyperlipidemics",
	"description": "reviewing various drugs used in hyperlipidemia",
	"date": "2024-09-29 21:53",
	"author": "ayobami",
	"data": {
		"major class of drugs used in hyperlipidemia": [
			"statins",
			"fibrates",
			"nicotinic acid",
			"bile acid resins",
			"cholesterol absorption inhibitors"
		],
		"a type of the newer anti-hyperlipidemic drugs": [
			"PCSK9-inhibitors",
			"APO-B synthesis inhibitor",
			"thyromimetics",
			"MTTP inhibitor",
			"CETP inhibitor"
		],
		"full meaning of MTTP": [
			"microsomal triglyceride transport protein"
		],
		"full meaning of CETP": [
			"cholesterol ester transport protein"
		],
		"full meaning of PCSK-9": [
			"proprotein convertase subticilin kexin 9"
		],
		"class I": [
			"statins"
		],
		"class II": [
			"nicotinic acid"
		],
		"class III": [
			"bile acid resins"
		],
		"class IV": [
			"fibrates"
		],
		"class V": [
			"cholesterol absorption inhibitors"
		],
		"a statin": [
			"rosuvastatin",
			"atorvastatin",
			"simvastatin",
			"pravastatin",
			"lovastatin",
			"pitavastatin"
		],
		"most potent statin": [
			"rosuvastatin"
		],
		"statin with highest HDL increase effect": [
			"simvastatin"
		],
		"drug that reduces fibrinogen": [
			"pravastatin",
			"fenofibrate"
		],
		"least potent statin": [
			"lovastatin"
		],
		"2nd most potent statin": [
			"atorvastatin"
		],
		"3rd most potent statin": [
			"simvastatin"
		],
		"4th most potent statin": [
			"pravastatin"
		],
		"a bile acid resin": [
			"cholesevelam",
			"colestipol",
			"colestyramine"
		],
		"best bile acid resin": [
			"cholesevelam"
		],
		"non-antihyperlipidemic drug that bile acid resins interact with": [
			"digoxin",
			"morphine",
			"thyroxine"
		],
		"class of drugs bile acid resins interact with": [
			"statins"
		],
		"MOA of statins": [
			"inhibition of HMG-CoA synthase"
		],
		"MOA of ezetimibe": [
			"inhibition of NPC1C1"
		],
		"MOA of fibrates": [
			"activation of PPAR-ùù∞"
		],
		"a fibrate": [
			"gemfibrozil",
			"fenofibrate",
			"benzafibrate"
		],
		"a steroid absorption inhibitor": [
			"ezetimibe"
		],
		"a PCSK-9 inhibitor": [
			"evolocumab",
			"alirocumab",
			"bococizumab"
		],
		"an APO-B synthesis inhibitor": [
			"mipomersen"
		],
		"a MTTP inhibitor": [
			"lopitamide"
		],
		"a thyromimetic": [
			"eprotirome"
		],
		"a CETP": [
			"dalcetrapibe",
			"torcetrapibe"
		],
		"fibrate that has no myopathy": [
			"benzafibrate"
		],
		"drug that reduces TGs by ~40%": [
			"nicotinic acid"
		],
		"drug that increases HDL by ~20-30%": [
			"nicotinic acid"
		]
	}
}
